| Literature DB >> 31583373 |
Mohammad Mehdi Heidari1, Amirhossein Danafar2, Fahime Moezzi1, Mehri Khatami1, Ali Reza Talebi3.
Abstract
BACKGROUND: Numerous researches have provided great evidence that revealed the relationship between varicocele and sperm DNA damage.Entities:
Keywords: Genetic polymorphism; Infertility; Nuclear transition protein 2; Varicocele
Year: 2019 PMID: 31583373 PMCID: PMC6745086 DOI: 10.18502/ijrm.v17i8.4821
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
Mean and standard deviation of sperm parameters of patients and participants of the variants, SIFT and PolyPhen (sequence homology-based tools) were used.
| Variables | Varicocele (n░=░156) | Control (n░=░150) | P-value* |
|---|---|---|---|
| Age | 28.3░±░5.63 | 29.7░±░6.14 | 0.790 |
| Count (mil.ml-1) | 46.20░±░44.29 | 106.20░±░58.39 | 0.000 |
| Rapid motility (%) or grade a | 11.03░±░9.72 | 26.32░±░6.89 | 0.000 |
| Slow motility (%) or grade b | 32.01░±░8.14 | 29.12░±░3.68 | 0.615 |
| Non-progressive motility (%) or Grade c | 17.56░±░8.32 | 10.41░±░3.01 | ≤ 0.001 |
| Normal morphology (%) | 26.80░±░15.35 | 41.98░±░8.13 | ≤ 0.001 |
Differences between variables with normal distribution were analyzed the Chi-square goodness-of-fit test
Primers used for amplification with PCR
| Primer sequence (5'-3') | Primer size (bp) | Exon | Amplicon size (bp) |
|---|---|---|---|
| 20 | 1 | 440 | |
| 20 | |||
| 22 | 2 | 127 | |
| 20 |
Figure 1(A) The SSCP patterns of exon 2 of TNP2 gene. (B) The results of direct sequencing of exon 2 of TNP2 gene revealed g.IVS1-26G░>░C (rs8043625). Lanes 3, 4, and 6 show G/G, C/C, and C/G genotypes, respectively. Also, lanes 1, 2, and 5 have G/G genotype and lane 7 similar to lane 6 has C/G.
Genotype distribution and relative allele frequencies of rs8043625 (g.IVS1-26G░>░C) polymorphism in the TNP2 gene among Varicocele and control group
| rs8043625 (g.IVS1-26G░>░C) | Patients (n░=░156) | Controls (n░=░150) | OR (95% CI) | P-value |
|---|---|---|---|---|
| Codominant model | ||||
| GG | 40 (25.6%) | 76 (50.7%) | 1 (ref.) | |
| GC | 70 (44.9%) | 56 (37.3%) | 1.250 (0.880–1.776) | 0.213 |
| CC | 46 (29.5%) | 18 (12.0%) | 2.556 (1.482–4.407) | 0.001 |
| Dominant model | ||||
| GG | 40 (25.6%) | 76 (50.7%) | 1 (ref.) | |
| GC░+░CC | 116 (74.4%) | 74 (49.3%) | 2.98 (1.84–4.82) | 0.000 |
| Recessive model | ||||
| GG░+░GC | 110 (70.5%) | 132 (88.0%) | 1 (ref.) | |
| CC | 46 (29.5%) | 18 (12.0%) | 3.07 (1.68–5.59) | 0.000 |
| Over-dominant model | ||||
| GG░+░CC | 86 (55.1%) | 94 (62.7%) | 1 (ref.) | |
| GC | 70 (44.9%) | 56 (37.3%) | 1.37 (0.86–2.16) | 0.000 |
| Allele frequency | ||||
| G | 208 (69.30%) | 150 (48.1%) | 2.442 (1.754–3.400) | p < 0.001* |
| C | 92 (30.70%) | 162 (51.9%) | ||
P-value by Chi-square goodness-of-fit test
Haplotype analysis of TNP2 polymorphisms with Varicocele patients and in controls
| Haplotype | Patients (n░=░156) | Controls (n░=░150) | OR (95% CI) | P-value |
|---|---|---|---|---|
| G/C/T* | 79 (50.64) | 105 (70.00) | 1 (ref.) | |
| G/C/C | 21 (13.46) | 22 (14.67) | 1.269 (0.652–2.468) | 0.483 |
| G/T/T | 7 (4.49) | 3 (2.00) | 3.101 (0.777–12.372) | 0.108 |
| G/T/C | 3 (1.92) | 2 (1.33) | 1.994 (0.325–12.217) | 0.455 |
| C/C/T | 37 (23.72) | 15 (10.00) | 3.278 (1.682–6.389) | 0.000 |
| C/C/C | 7 (4.47) | 2 (1.33) | 9.878E-9 (0.000) | 0.998 |
| C/T/T | 1(0.64) | 1 (0.67) | 9.304 (1.122–77.165) | 0.038 |
| C/T/C | 1 (0.64) | 0 (0.00) | - | - |
OR: Odds ratio; CI, Confidence interval
G/C/T haplotype were shown for g.IVS1-26G░>░C/c.301C░>░T/c.391░T░>░C polymorphisms, respectively
P-value by Chi-square goodness-of-fit test
Figure 2A three-dimensional structure model prediction of TP2 protein using the Protein Model Portal server and showing a close-up of the R101 (A) and C101 residues (B), R131 (C) and W131 (D) using PyMol.
Predicted results of the pathogenicity of rs34904070 (P.101 R░>░C) and rs11640138 (P.131 R░>░W) variants with SIFT and PolyPhen tools
| Predictor | Variation | Score | Prediction |
|---|---|---|---|
| P.101 R░>░C | 0.02 | AFFECT PROTEIN FUNCTION | |
| P.131 R░>░W | 0.00 | AFFECT PROTEIN FUNCTION | |
| P.101 R░>░C | 0.096 | BENIGN | |
| P.131 R░>░W | 0.886 | POSSIBLY DAMAGING |
Genotype distribution and relative allele frequencies of rs34904070 (c.301C░>░T) polymorphism in the TNP2 gene among Varicocele and control group
| rs34904070 (c.301C░>░T) | Patients (n░=░156) | Controls (n░=░150) | OR (95% CI) | P-value |
|---|---|---|---|---|
| Codominant model | ||||
| CC | 78 (50%) | 84 (56%) | 1 (ref.) | |
| CT | 66 (42%) | 60 (40%) | 1.10 (0775–1.560) | 0.593 |
| TT | 12 (7.7%) | 6 (4%) | 2.00 (0.571–5.329) | 0.166 |
| Dominant model | ||||
| CC | 78 (50%) | 84 (56%) | 1 (ref.) | 0.293 |
| CT░+░TT | 78 (50%) | 66 (44%) | 1.27 (0.81–2.00) | |
| Recessive model | ||||
| CC░+░CT | 144 (92.3%) | 144 (96%) | 1 (ref.) | 0.165 |
| TT | 12 (7.7%) | 6 (4%) | 2.00 (0.73–5.47) | |
| Over-dominant model | ||||
| CC░+░TT | 90 (57.7%) | 90 (60%) | 1 (ref.) | 0.681 |
| CT | 66 (42.3%) | 60 (40%) | 1.10 (0.70–1.73) | |
| Allele frequency | ||||
| C | 228 (76%) | 222 (71.15%) | ||
| T | 72 (24%) | 90 (28.85%) | 0.779 (0.543–1.117) | 0.199 |
P-value by Chi-square goodness-of-fit test
Genotype distribution and relative allele frequencies of rs11640138 (c.391░T░>░C) polymorphism in the TNP2 gene among Varicocele and control group
| rs11640138 (c.391░T░>░C) | Patients (n░=░156) | Controls (n░=░150) | OR (95% CI) | P-value |
|---|---|---|---|---|
| Codominant model | ||||
| TT | 54 (34.6%) | 60 (40%) | 1 (ref.) | |
| CT | 70 (44.9%) | 64 (42.7%) | 1.094 (0.779–1.535) | 0.604 |
| CC | 32 (20.5%) | 26 (17.3%) | 1.231 (0.734–2.065) | 0.432 |
| Dominant model | ||||
| TT | 54 (34.6%) | 60 (40%) | 1 (ref.) | |
| CT░+░CC | 102 (65.4%) | 90 (60%) | 1.26 (0.79–2.00) | 0.330 |
| Recessive model | ||||
| TT░+░CT | 124 (79.5%) | 124 (82.7%) | 1 (ref.) | |
| CC | 32 (20.5%) | 26 (13.3%) | 1.23 (0.69–2.19) | 0.477 |
| Over-dominant model | ||||
| TT░+░CC | 86 (55.1%) | 86 (57.3%) | 1 (ref.) | |
| CT | 70 (44.9%) | 64 (42.7%) | 1.09 (0.70–1.72) | 0.697 |
| Allele frequency | ||||
| T | 184 (61.33%) | 178 (57.05%) | ||
| C | 116 (38.67%) | 134 (42.95%) | 0.837 (0.606–1.157) | 0.286 |
P-value by Chi-square goodness-of-fit test